Featured Research

from universities, journals, and other organizations

Stroke's 'death signal' can be blocked; discovery may aid drug development

Date:
January 25, 2010
Source:
University of Central Florida
Summary:
Biomedical scientists have identified a way to block a "cell death signal" that they believe triggers brain damage during strokes.

Dr. Sic Chan is an assistant professor at the University of Central Florida in Orlando.
Credit: UCF/Jacque Brund

Biomedical scientists from the University of Central Florida and Louisiana State University have identified a way to block a "cell death signal" that they believe triggers brain damage during strokes.

Strokes, also known as cerebral ischemia, are caused by inadequate blood flow to the brain and are the third-leading cause of death in the United States.

The team's work focused on a neurotransmitter that typically plays an important role in communication among nerve cells in the brain and fosters learning and memory. This glutamate neurotransmitter opens the NMDA (N-methyl-D-aspartate) receptors, allowing the entry of calcium into the nerve cells.

Under normal conditions, the activity of the NMDA receptors is tightly regulated to prevent nerve cells from becoming overloaded with calcium. During a stroke, however, that process of regulation breaks down. The excessive influx of calcium through NMDA receptors kills the nerve cells and can cause severe brain damage.

Striving to prevent such calcium overloads, the research team discovered that an enzyme, DAPK1 (Death-Associated Protein Kinase 1), binds to a portion of the NMDA receptor and acts as a "cell death signal" during strokes.

Researchers hypothesized that by preventing DAPK1 from binding with the NMDA receptors, they could prevent the calcium overloads and cell deaths. They developed a potent compound to test their theory and found that the compound blocked DAPK1, protecting brain cells against stroke injury, and did not affect the beneficial physiological functions of the receptors.

The findings appear in the Jan. 22 issue of Cell, one of the leading journals in the field.

"It is conceivable that this study not only provides new insights into the cellular and molecular basis responsible for stroke damage, but also provides a therapeutic target for stroke therapy," said Youming Lu, the LSU professor who led the team of scientists.

The findings also may have significant implications for developing therapeutic drugs to treat other neurodegenerative diseases, said UCF Assistant Professor Sic Chan, a study collaborator who has done extensive research on the role of calcium in neurodegenerative diseases such as Alzheimer's and Parkinson's.

"Anytime we gain an increased understanding of the molecular mechanism of neurodegeneration, that enhances our ability to make better drugs," he said.

To date, all stroke clinical trials targeting glutamate receptors have failed, largely because of their side effects, an inefficient delivery of compounds from the blood to the brain or the length of time it takes for the drugs to work effectively.


Story Source:

The above story is based on materials provided by University of Central Florida. Note: Materials may be edited for content and length.


Journal Reference:

  1. Weihong Tu, Xin Xu, Lisheng Peng, Xiaofen Zhong, Wenfeng Zhang, Mangala M. Soundarapandian, Cherine Balel, Manqi Wang, Nali Jia, Wen Zhang, Frank Lew, Sic Lung Chan, Yanfang Chen, Youming Lu. DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke. Cell, 2010; DOI: 10.1016/j.cell.2009.12.055

Cite This Page:

University of Central Florida. "Stroke's 'death signal' can be blocked; discovery may aid drug development." ScienceDaily. ScienceDaily, 25 January 2010. <www.sciencedaily.com/releases/2010/01/100121135846.htm>.
University of Central Florida. (2010, January 25). Stroke's 'death signal' can be blocked; discovery may aid drug development. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2010/01/100121135846.htm
University of Central Florida. "Stroke's 'death signal' can be blocked; discovery may aid drug development." ScienceDaily. www.sciencedaily.com/releases/2010/01/100121135846.htm (accessed September 21, 2014).

Share This



More Mind & Brain News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Food Addiction Might Be Caused By PTSD

Food Addiction Might Be Caused By PTSD

Newsy (Sep. 18, 2014) New research shows that women who suffer from PTSD are three times more likely to develop a food addiction. Video provided by Newsy
Powered by NewsLook.com
Corporal Punishment on Decline, Debate Renews

Corporal Punishment on Decline, Debate Renews

AP (Sep. 16, 2014) Corporal punishment in the United States is on the decline, but there is renewed debate over its use after Minnesota Vikings running back Adrian Peterson was charged with child abuse. (Sept. 16) Video provided by AP
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins